The Level of Soluble FMS-Like Tyrosinkinase-1, Placental Growth Factor and Vitamin E in Pre-Eclampsia and Normotensive Pregnancy
- 1 Faculty of Medicine, University of Sam Ratulangi, Manado, Indonesia
- 2 Faculty of Medicine, University of Sam Ratulangi, Manado, Indonesia
- 3 Faculty of Medicine, University of Sam Ratulangi, Manado, Indonesia
Abstract
Background: This study aims to determine the differences of angiogenic markers sFlt-1 (soluble FMS-like tyrosine kinase-1), Placental Growth Factor (PlGF) and antioxidant (vitamin E) levels in pre-eclampsia compared with normotensive pregnancies. Methods: In a cross-sectional study performed on 40 normotensive pregnancies and 40 pre-eclampsia women, serum levels of sFlt-1, PlGF and vitamin E were measured with ELISA methods. Statistical analysis used Mann Whitney. Results: The serum levels from the group of normotensive pregnancy and pre-eclampsia women consecutively are as follows: sFlt-1 2251.32 ± 416.17 pg/mL and 2950.78 ± 221.34 pg/mL, having a very significant difference (p = 0.00); PlGF 391.67 ± 293.92 pg/mL and 150.15 ± 105.34 pg/mL, having a very significant difference; vitamin E 8537.21 ± 6299.74 unit and 700.61 ± 233.70 unit, having a very significant difference. Conclusion: There is a very significant difference between an-giogenic markers and antioxidant levels in pre-eclampsia and normotensive pregnancies.
- Cunningham, F.G., Leveno, K.J., Bloom, S.L., Hauth, J.C., Rouse, D.J. and Spong, C.Y., Eds. (2014) Williams Obstetrics. 24th Edition, McGraw Hill, New York.
- Wagner, L.K. (2004) Diagnosis and Management of Pre-Eclampsia. American Family Physician, 70, 2317-2324.
- Emery, P.S. (2005) Hypertensive Disorders of Pregnancy: Overdiagnosis Is Appropriate. Cleveland Clinic Journal of Medicine, 72, 345-352. http://dx.doi.org/10.3949/ccjm.72.4.345
- Barton, J.R. and Sibai, B.M. (2007) Pre-Eclampsia. In: Manual of Obstetrics, 7th Edition, Lippincott Williams & Wilkins, Texas.
- Alkaff, T.R., Hartini, T.N.S. and Hakimi, M. (2008) The Correlation between Seasonal Variation and Pre-Eclampsia in Dr. Sardjito Hospital, Yogyakarta, 1999-2003. Majalah Obstet Ginekol Indones, 32, 139-142.
- Wang, A., Rana, S. and Karumanchi, S.A. (2009) Pre-Eclampsia: The Role of Angiogenic Factors in Its Pathogenesis. Physiology, 24, 147-158. http://dx.doi.org/10.1152/physiol.00043.2008
- Baumann, M.U., Bersinger, N.A., Mohaupt, M.G., Raio, L., Gerber, S. and Surbek, D.V. (2008) First-Trimester Serum Levels of Soluble Endoglin and Soluble FMS-Like Tyrosine Kinase-1 as First-Trimester Markers for Late-Onset Pre-Eclampsia. American Journal of Obstetrics Gynecology, 199, 266.e1-266.e6. http://dx.doi.org/10.1016/j.ajog.2008.06.069
- Davidson, J.M., Homuth, V., Jeyabalan, A., Conrad, K.P., Karumanchi, S.A., Quagging, S., et al. (2004) New Aspect in the Pathophysiology of Pre-Eclampsia. Journal of the American Society of Nephrology, 15, 2440-2448. http://dx.doi.org/10.1097/01.ASN.0000135975.90889.60
- Levine, R.J., Qian, C., Maynard, S.E., Yu, K.F., Epstein, F.H. and Karumanchi, S.A. (2006) Serum sFlt1 Concentration during Pre-Eclampsia and Mid Trimester Blood Pressure in Healthy Nulliparous Women. American Journal of Obstetrics Gynecology, 194, 1034-1041. http://dx.doi.org/10.1016/j.ajog.2005.10.192
- Stepan, H. (2009) Angiogenic Factors and Pre-Eclampsia: An Early Marker Is Needed. Clinical Science (London), 116, 231-232. http://dx.doi.org/10.1042/CS20080598
- Dechend, R. and Luft, F. (2008) Angiogenesis Factors and Preeclampsia. Nature Medicine, 14, 1187-1188. http://dx.doi.org/10.1038/nm1108-1187
- Noris, M., Perico, M. and Remuzzi, G. (2005) Mechanism of Disease: Pre-Eclampsia. Nature Clinical Practice Nephrology, 1, 98-114. http://dx.doi.org/10.1038/ncpneph0035